Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
- Final launch window determination
- Activate flight recorders
- Final "go/no-go" launch polls conducted by Anavex management team and directors
- Start automatic ground launch sequencer with pending TLR, CTAD, and peer review
- Retract orbiter access arm and ready GABA Glutamate regulation(T-7 minutes, 30 seconds)
- Start auxiliary SIGMAR1 power units (T-5 minutes, 0 seconds)
- Arm solid rocket booster range safety safe and no side effects (T-5 minutes, 0 seconds)
- Start orbiter aerosurface homeostasis profile test, followed by main engine gimbal profile test and autophagy (T-3 minutes, 55 seconds)
- Retract gaseous oxygen vent arm, or "beanie cap" (T-2 minutes, 55 seconds)
- Crew members close and lock their visors and prepare to meet all primary and secondary endpoints (T-2 minutes, 0 seconds)
- Orbiter transfers from ground to internal power increased MMSE scores (T-50 seconds)
- Ground launch sequencer is go for auto sequence chromatin start (T-31 seconds)
- Activate launch pad dementia suppression reversal system (T-16 seconds)
- Activate main engine hydrogen burnoff system and share price appreciation system (T-10 seconds)
- Main engine start (T-6.6 seconds)
- Solid rocket booster ignition...
Surely such a PR with high dose halting and/or reversing 100% of patients would be worthy of a mid-day halt and PR.
No worries. Let us all not waste our time responding to maggots. They'll all get fried when Missling releases the TLD and we'll never hear from them again.
They have definitely gone over the terms of any agreement they would accept with a potential BP partner since they know it's inevitable.
Missling knew we had this over three years ago. That's why it was so important for him to get us to approve the blank check preferreds so we would be protected from a BP hostile takeover. He even went as far as to mail out a plea to shareholders. Remember this from 2019? He knew back then that BP would be drooling to take us out and he wasn't going to let that happen. He may not be timely but he sure is forward thinking and a few chess moves ahead. We got this and we will soon be negotiating from a position of strength. Buckle up because this is going to be an awesome wild ride!
Thanks Mayo. Great write up! Exciting times ahead for us.
1010 Wins just interviewed an Alzheimer’s doctor at Northwell Hospital about Biogen's new Alzheimer’s drug. He said the results are similar to their last drug and not too impressive so we shouldn't get our hopes up since we still have a lot of work to do. Time for Anavex to take the lead!
No doubt the corrupt FDA is in bed with their BP buddies but with our > 20 MMSE and high dose we should blow them out of the water. No company has ever (in Missling's words) "reversed" dementia or came out of a trial with "less dementia". If we show reversal and stabilization in some patients, how could they ignore that. Never been done before except with Anavex. "Less Dementia!"
Missling is laughing at Esai's results right now and HH knows it. They may have had a slight slowing of the disease but I bet they don't know why since they don't use precision medicine. Perhaps they tickled Sigma 1 a very tiny bit but they wouldn't know since they are looking for an Amyloid response.
Can you imagine all those BPs spending all that money and time on Amyloid and this little company comes along and eats your cake making your drug obsolete?
The storm is coming and it's called Anavex!
I guess emoji's don't work on the app. That was supposed to be a thumbs up but it's showing as two question marks. Oh well. Thumbs Up!
Thumbs Up!
Everyone is talking about about the FDA but Australia, Canada, Germany and the UK have a closer connection to these trials since that's where they took place. The Aussies and these other locations should move on a successful readout. The Aussies wouldn't help with these trials and special access and ignore successful results. We should at minimum get PA and the rest will follow.
Yup, the substantive scientific educational videos takes all the wind out of any naysayer's sails. It's all laid out on the table for all to see. Game point!
https://www.anavex.com/vnrjune2022
MOMO Run Up to $120 - $130 seems to be the Alzheimer's stock playbook. Happened with CRTX, ANVS and SAVA. We're a bit overdue but any one of our upcoming PRs could put us into play. However, unlike these others, we're the real deal so the pull back won't be as drastic, and any pullback will be followed with a steady climb into Alzheimer's readout.
HIV Drug Maraviroc Could Combat Memory Loss
Could Leronlimab work even better?
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=168972611
Email to IR this morning urging clarification. Many do not read IBD.
-----------------------------------------------
Dear Clint,
Members of my family and I are long term investors in Anavex with very large holdings, acquiring over the last 7 years. We were all very disappointed with the handling of yesterday's Retts data PR. Although the data was excellent, it was left unclear why or when the updates were made to the Clinical Trials database. This left a wide opening for the process, endpoints, and company integrity to be questioned and attacked.
We would like to urge Dr. Missling to release a PR from Anavex clarifying what happened. A statement on the company website and to IBD is insufficient. My parents, who have a large holding of Anavex in a trust account for their grandchildren, had to call me yesterday to ask what was going on. They do not frequent message boards or read IBD. Like many average investors, they mainly rely on PRs from the company and the news feed from their brokerage accounts. IBD headlines do not appear in their brokerage news feed. Without a clarification PR, many will be left in the dark and confused about what's going on with their Anavex investment.
Dr. Missling needs to issue a PR to clarify when and why the changes were made so that the average investor in Anavex has access to the information. Transparency is important and investors should be given the courtesy of clarification.
Regards
Yes, when they PR'd it, they obviously expected to have it done and recorded by the 10th. However, Missling may have decided to delay for some reason (ie. new data) so it hasn't happened yet. Hopefully, it happens tomorrow morning after a PR and then Missling gets to do a double header with JPM.
Ha, hoping it's not weeks/months then, pursuant to the "usual Anavex margin of timing error." Usually they are a little more vague like "around", "near", "about" so I was hoping when they do state a specific hard date that they would stand by it. Hopefully the delay is due to trying to get in some new data.
"A webcast of the on-demand presentation will be available beginning Monday, January 10, 2022 on the Company's website..."
The H.C Wainwright presentation should have been posted on Monday the 10th according to Anavex's PR but hasn't shown up yet. https://www.anavex.com/post/anavex-life-sciences-to-present-at-the-h-c-wainwright-virtual-bioconnect-2022-conference
Does anyone know whether this has been posted for those registered for the conference or has this been delayed for them as well?
Anavex now! Implanted chip automatically euthanizes at first sign of dementia.
Chip implant automatically euthanizes at first sign of dementia.
Time for Missling to unblind and release the Kraken to devour amyloid theory and all the other Alzheimer’s companies. Time for him to use the nuclear option and end this once and for all.
Agree, I think this theory would be giving the FDA too much credit. They are not that cunning. The corrupt FDA was just doing what they always do helping their buddies in BP.
Regardless, Missling was a genius to go to Australia knowing that we didn't stand a chance here against the FDA and BP. Hopefully, after this peer review and data readouts coupled with all the RWE they're seeing in the OLE, an unblinding will happen soon followed by Aussie PA or approval.
True, while all the other BPs and FDA are busy with their checkers and constant shouts of "King Me", Missling has been setting them all up for the ultimate checkmate!
No haircuts if we want to win. Remember Samson.
This is the exact reason Dr Randi Hagerman said she wanted to take Blarcamesine for. I would love to be able to take some too. It's going to be like the movie Cocoon.
The increased social media presence and push to get the word out via new methods shows confidence and excitement in what we have. Dr. Missling is very reserved and wouldn't want to over promote the company if they didn't have the goods. Hopefully he can give us some substantive data. Like many others, I voted NO to the additional authorized shares; however, I'm open to Dr. Missling changing my mind and my vote.